Pillstats
Labeler · US market

Lilly S.A.

Lilly S.A. is a US drug labeler with US FDA registrations covering 1 drug concept (1 currently active) across 1 packages.

ACTIVE — US
openFDA · updated weekly
Labeler codes71210
Active drugs1
Registrations1 active / 1
Packages1
Sole supplier of0 drugs

Portfolio1 drugs · US

Every drug concept this labeler has US registrations for, by package count.

DrugTypeNDCsPackagesStatus
Raloxifene Hydrochloride
tablet
other11SUPPLYING